IL15 and neoplasm: It was also shown that splenocytes from the mice injected with the IL-15:IL-15Rα-B16F10-OVA vaccine enhanced tumor antigen (OVA)-specific cytotoxicity against both B16F10-OVA and E.G7-OVA when they were stimulated with an OVA peptide in vitro.